Fred Oudshoorn

NIBC Bank NV engages in the provision of investment banking and financial services. The firm offers advises on mergers, acquisitions, financial policy, and property financing, lending, leveraged finance, and derivatives. It provides asset financing to corporate lending, leveraged finance, oil and gas services, infrastructure, real estate, and shipping Sector. The company was founded in 1945 and is headquartered in The Hague, the Netherlands.

Gimv Nederland BV (Gimv-Nederland) is the Netherlands-based private equity subsidiary of GIMV Corporate Investment, which in turn is a subsidiary of Gimv NV (XB: GIMB) in Belgium. Established in 1983, Gimv-Nederland was formerly known as Halder Invest BV and became part of the Gimv Group in 2000. The firm is located in The Hague with additional offices in Frankfurt and Antwerp. Their clients include fund of funds, insurance companies, banks, corporations and pension funds.

Synergia Capital Partners BV is an independent private equity investment firm based in Veenendaal, the Netherlands. Founded in 1999, they specialize in the mid-size market of Dutch firms. Synergia operates through a range of transactions such as MBOs/MBIs, BIMBOs, public-to-private, growth finance and secondary offerings.

Value Creation Capital BV (VCC) is an independent private equity firm headquartered in Bilthoven, Netherlands. The firm was founded in 2005 by Aldebert Wiersinga and Jos Bourgonje.

Acision BV provides mobile engagement services. The firm's products and solutions include carrier infrastructure, acision enterprise network and consumer messaging services. It offers messaging services, which can make mobile communications experience and create new opportunities for carriers and enterprises. The company was founded in June 2007 and is headquartered in Nieuwegein, the Netherlands.

i-Optics BV develops and produces eye diagnosis and therapeutic solutions. Its lead product, the EasyScan, that provides non-mydriatic retina imaging camera for the diagnosis of diabetic retinopathy and macular degeneration. The firm engages in the development and marketing of retina and cornea imaging solutions. The company was founded by Michiel Mensink and is headquartered in The Hague, the Netherlands.

ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands.

Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn.

Regionale Ontwikkelingsmaatschappij InnovationQuarter BV (Innovation Quarter) is an independent venture capital firm headquartered in The Hague, the Netherlands. The firm was founded in 2013.

KPN Ventures BV (KPN Ventures) is a venture capital subsidiary of Royal KPN NV (KPN: NL), founded in 2015. The firm is headquartered in Amsterdam.